CTOs on the Move

National Hospice Medical Equipment

www.nationalhme.com

 
National HME is accredited by HQAA for Hospice Medical Equipment Services, as well as Clinical Respiratory Services. * National HME provides equipment for hospice patients 24/7 at no additional cost to the hospice program. * National HME provides simplified billing allowing your program more time to devote to patient care while reducing the hassle of HME bill reconciliation. Most contracts offered to hospice programs promote all-inclusive packaging with minimal extra charges allowing you the peace of mind that comes with understanding the exact cost for HME. * National HME maintains a minimal amount of warehoused equipment to streamline and work efficiently in ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Mike Tarpley
Vice President and Chief Technology Officer Profile

Similar Companies

Victor Medical

Victor Medical is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hart Enterprises Inc

Hart Enterprises Inc is a Sparta, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accutron Inc.

Accutron Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Osceola Supply Inc

Osceola Supply Inc is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Motif Neurotech

Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.